<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Involvement of the <z:chebi fb="0" ids="16856">glutathione</z:chebi> system is well established in <z:hpo ids='HP_0001297'>stroke</z:hpo>-induced <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory dysfunction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of the present study was to investigate the effects of <z:chebi fb="0" ids="41423">celecoxib</z:chebi> (a selective cyclooxygenase-2 [COX-2] inhibitor), <z:chebi fb="0" ids="44445">nimesulide</z:chebi> (a preferential COX-2 inhibitor), and <z:chebi fb="1" ids="5855">ibuprofen</z:chebi> (a nonselective COX-2 inhibitor) against bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (BCCAO)-induced <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory dysfunction</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>BCCAO for 30 minutews, followed by 24-hour reperfusion, significantly delayed transfer latency in the plus-maze performance task and shortened fall-off time in the hanging-wire experimental test </plain></SENT>
<SENT sid="3" pm="."><plain>Besides significant alterations in <z:chebi fb="0" ids="16856">glutathione</z:chebi> defense (i.e., <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase and redox ratio), increased acetylcholinesterase activity and proinflammatory marker (<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha TNF-α) in the hippocampus was seen </plain></SENT>
<SENT sid="4" pm="."><plain>Seven days of treatment with <z:chebi fb="0" ids="41423">celecoxib</z:chebi> (3 and 10 mg/kg, p.o.), <z:chebi fb="0" ids="44445">nimesulide</z:chebi> (10 mg/kg, p.o.), and <z:chebi fb="1" ids="5855">ibuprofen</z:chebi> (30 mg/kg, p.o.) significantly improved behavioral alterations and <z:chebi fb="0" ids="16856">glutathione</z:chebi> defense and attenuated acetylcholinesterase activity and TNF-α levels, as compared to the control (i.e., ischemic reperfusion) group </plain></SENT>
<SENT sid="5" pm="."><plain>The present study highlights the neuroprotective effect of <z:chebi fb="0" ids="41423">celecoxib</z:chebi> and <z:chebi fb="0" ids="44445">nimesulide</z:chebi> against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> reperfusion injury-induced <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory dysfunction</z:e>, neuroinflammation, and oxidative damage </plain></SENT>
</text></document>